1-1 of 1
Mesa A. Ruben, MD
Close
Sort by
Journal Articles

Presence of Unfavorable Cytogenetic Abnormalities Is the Strongest Predictor of Poor Survival in Secondary Myelofibrosis.

David Dingli, MD, PhD, Schwager M. Schwager, Mesa A. Ruben, MD, Chin Yang Li, MD, Ayalew Tefferi, MD
Journal: Blood
Blood (2005) 106 (11): 2585.
https://doi.org/10.1182/blood.V106.11.2585.2585
Published: 2005